Thanks to your generous support of The Christie, incredible innovations have been achieved in cancer research.
In the 1970s, 1 in 4 people survived cancer. Today, survival rates have doubled.
Despite progress, survival rates are still very low for some cancers, such as pancreatic, lung, oesophageal and brain tumours. By 2030 the number of new cases is likely to increase from 333,000 to 425,000 each year.
Research is the key to giving even more families hope in the future.
A world-leading cancer research centre
In April 2017 the Paterson building was destroyed by fire. Thankfully nobody was injured and the majority of valuable research materials were salvaged, but over 300 scientists and support staff were displaced.
The Christie explored repairing the building but concluded either keeping the building in its current state or refurbishing it would not be feasible.
Research staff have been temporarily relocated 13 miles away at Alderley Park to continue their work, however their distance from colleagues and patients presents an obvious barrier to their collaborative approach.
Improving patient outcomes and survival
The Paterson redevelopment will give more patients access to clinical trials, fast-forwarding our progress in improving patient outcomes and survival.
This venture will be led by The Christie in partnership with Cancer Research UK and University of Manchester which is already a successful 10 year partnership. It is a proven concept that through these three parties working together it creates great strides forward in cancer research and cancer care.
You can read about the project's process and what we're currently working on on our Paterson redevelopment project page.
With your help, £50 million needs to be raised to realise a shared vision for the future of cancer research.
Quality specialist staff
300 research scientists, support staff and clinicians will be rehoused in a purpose-built space, including members of the internationally renowned Cancer Research UK Manchester Institute (CRUK MI).
A further 400 staff will also be housed, more than doubling the capacity of the 300 researchers and support staff who were previously based in the Paterson building.
Centre of excellence
We will develop a world-leading centre of excellence for biomarker discovery, validation and clinical qualification.
Closer working together
Joint-appointed academic clinician scientists and research active clinical consultants will be co-located, fostering closer interactions to drive the translational and clinical research agenda.
Future-proofing our work
We will provide for future growth of discovery and clinical academic research, drug discovery, prevention and early detection research.
The CRUK MI will be rehoused in the new building with the potential for development, integration and expansion of new activities.
Improving patient outcomes
We will enhance the translation of proven research into clinical service delivery, leading to improvements in patient outcomes not just in Greater Manchester, but nationally and internationally.
For Manchester and for the world
The Paterson redevelopment is not a project to fund a new building; it is a project to extend and improve lives. Together, we have a responsibility to do everything we can for patient outcomes in Greater Manchester and for everyone touched by cancer across the UK and the world.
By supporting this ambitious project, you will help improve cancer survival and give people more time with their loved ones, bringing hope to thousands of families who face cancer every day.
Select Paterson Rebuild from the designation menu to make sure your donation goes to your chosen cause.